Source: Eur Respir J 2015; 45: 831-833



Rating:

Share or cite this content

Citations should be made in the following way:
Epaud Ralph, Ducou Le Pointe Hubert, Fasola Sylvie, Ploussard Sandra, Delestrain Celine, Sileo Chiara, Donadieu Jean. Cladribine improves lung cysts and pulmonary function in a child with histiocytosis. Eur Respir J 2015; 45: 831-833

Member's Comments

No comment yet.

Related content which might interest you: Effect of cladribine therapy on lung cysts in pulmonary Langerhans cell histiocytosis Source: ERJ Open Res, 4 (1) 00089-2017; 10.1183/23120541.00089-2017 Year: 2018 Pulmonary hypertension in pulmonary Langerhans’ cell histiocytosis Source: Eur Respir Mon 2012; 57: 161-165 Year: 2012 Pulmonary Langerhans' cell histiocytosis Source: Respipedia Article Year: 2016 A case with pulmonary histiocytosis X and lung cancer Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Pulmonary hypertension in orphan lung diseases Source: Eur Respir Mon 2011; 54: 317-331 Year: 2011 Chemotherapy in patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 Pulmonary Langerhans‘ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular involvement via exercise tests Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Adult pulmonary Langerhans‘ cell histiocytosis and lung cancer Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer Year: 2009 Do high resolution CT findings predict lung function impairment in pulmonary Langerhans cell histiocytosis? Source: Eur Respir J 2002; 20: Suppl. 38, 59s Year: 2002 How I manage pulmonary Langerhans cell histiocytosis Source: Eur Respir Rev, 26 (145) 170070; 10.1183/16000617.0070-2017 Year: 2017 Pneumothorax in pulmonary langerhans cell histiocytosis (PLCH) Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Psychological abnormalities are commonly present in adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Lung transplantation for pulmonary Langerhans‘ cell histiocytosis Source: Eur Respir J 2005; 26: Suppl. 49, 635s Year: 2005 Influence of pregnancy on pulmonary function in women with pulmonary Langerhans cell histiocytosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Exercise in patients with pulmonary Langerhans cell histiocytosis: performance and mechanisms of limitation Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017 Effectiveness of chemotherapy treatment for patients with pulmonary Langerhans cell histiocytosis during long-term follow-up Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Severe lung involvement in systemic scleromyxoedema: a highly unusual finding Source: Eur Respir J 2002; 19: 976-979 Year: 2002 Ventilation disorders dynamics and morphological changes in patients with pulmonary Langerhans cell histiocytosis (PLCH) Source: International Congress 2015 – IIPs: orphan Year: 2015